More information than PSA alone—designed to help avoid unnecessary biopsies.
PSA can be elevated for reasons other than cancer (like benign enlargement or inflammation). That uncertainty can lead to “just in case” biopsies.
PHI combines three biomarkers into a single score that better stratifies risk in men who are being evaluated for possible prostate cancer. Used appropriately, it can help increase confidence when deciding whether biopsy is warranted.
Good healthcare is a conversation. ProstateGuard gives you additional information to bring to that conversation—so you can better understand your risk, ask informed questions, and participate confidently in decisions about what comes next.
You’re not replacing your clinician. You’re showing up better prepared.
ProstateGuard is designed to support shared decision-making between you and your healthcare provider, including decisions about whether additional evaluation or biopsy may be appropriate.